Observe Medical ASA: Extraordinary general meeting held on 7 January 2025

07 Jan 2025 15:21 CET

Oslo, 7 January 2025

Reference is made to the stock exchange announcement by Observe Medical ASA
("Observe Medical" or the "Company", OSE ticker: OBSVR) on 17 December 2024
regarding notice of an extraordinary general meeting. The extraordinary general
meeting was held today, on 7 January 2025 at 10:00 (CET) at the Company's
offices in Haakon VIIs gate 1, 7th floor, 0161 Oslo, Norway.

The extraordinary general meeting resolved, amongst other, to adopt a
consolidation of the Company's shares (reverse share split) in the ratio 15:1 to
meet the Oslo Stock Exchange's requirement of a minimum market value of NOK 1
per share. To facilitate the share consolidation, the general meeting resolved
to increase the Company's share capital by NOK 1.30 through the issue of 5 new
shares, each with a nominal value of NOK 0.26, in order to obtain a total number
of shares divisible by 15. The Company will issue a separate stock exchange
announcement with the key dates for the share consolidation once such dates have
been determined.

The proposals regarding (i) an general authorisation to the board of directors
to increase the share capital in connection with financing of further growth and
(ii) a authorisation to the board of directors to increase the share capital in
connection with sett-off/contributions of loans and accounts payable etc., were
also approved.

The minutes from the extraordinary general meeting are enclosed hereto and will
also be available on the Company's website www.observemedical.com/investor
-relations.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical:

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialisation of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.

This information is subject to the disclosure requirements pursuant to Section 5
-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site

636064_Observe_Medical_ASA_Minutes_EGM_070125.pdf